https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:20 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/xvk7majvzr4-worlds-first-off-the-shelf-nk-cellular-immunotherapy/ Tue, 08 Sep 2020 16:05:35 +0000 http://vjregenmed.devbrandcast.com/video/xvk7majvzr4-worlds-first-off-the-shelf-nk-cellular-immunotherapy/ Troels Jordansen, Glycostem Therapeutics, Oss, The Netherlands, discusses the development of the world’s first off-the-shelf NK cellular immunotherapy in acute myeloid leukemia patients and subsequent clinical trials involving oNKord® cellular therapy. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]> https://mirror.vjregenmed.com/video/pjdhoxb9som-4-year-horizon-2020-itn-marie-curie-training-network/ Tue, 08 Sep 2020 16:05:35 +0000 http://vjregenmed.devbrandcast.com/video/pjdhoxb9som-4-year-horizon-2020-itn-marie-curie-training-network/ Troels Jordansen, of Glycostem Therapeutics, Oss, The Netherlands, discusses the 4-year Horizon 2020 ITN-Marie Curie training programme aiming to develop novel methods to manufacture tumor reactive NK cells.This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>